Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activities
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Cash from Operations (2017 - 2025)

Historic Cash from Operations for Selectis Health (GBCS) over the last 14 years, with Q3 2025 value amounting to $280028.0.

  • Selectis Health's Cash from Operations rose 12281.0% to $280028.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $814699.0, marking a year-over-year increase of 12502.68%. This contributed to the annual value of -$1.8 million for FY2024, which is 43995.76% down from last year.
  • Latest data reveals that Selectis Health reported Cash from Operations of $280028.0 as of Q3 2025, which was up 12281.0% from -$77379.0 recorded in Q2 2025.
  • In the past 5 years, Selectis Health's Cash from Operations ranged from a high of $2.4 million in Q3 2023 and a low of -$1.9 million during Q4 2023
  • In the last 5 years, Selectis Health's Cash from Operations had a median value of -$66995.0 in 2023 and averaged -$32936.3.
  • In the last 5 years, Selectis Health's Cash from Operations skyrocketed by 577294.51% in 2022 and then crashed by 63667.87% in 2023.
  • Selectis Health's Cash from Operations (Quarter) stood at $1.3 million in 2021, then plummeted by 74.1% to $345500.0 in 2022, then tumbled by 636.68% to -$1.9 million in 2023, then soared by 77.17% to -$423361.0 in 2024, then surged by 166.14% to $280028.0 in 2025.
  • Its Cash from Operations stands at $280028.0 for Q3 2025, versus -$77379.0 for Q2 2025 and $1.0 million for Q1 2025.